PD-120 FIDUCIAL MARKERS IN COMBINED EBRT-LDR THERAPY OF PROSTATE CANCER: INFLUENCE ON LDR DOSE

Autor:	D. de Haas-Kock, Frans Verhaegen, P. Visser, H. Afsharpour, F. van Gils, Brigitte Reniers, Lars H.P. Murrer, G. Landry, Ludy C.H.W. Lutgens
Rok vydání:	2012
Předmět:	Prostate cancer medicine.medical_specialty Oncology business.industry Urology Medicine Radiology Nuclear Medicine and imaging Hematology business Fiducial marker medicine.disease
Zdroj:	Radiotherapy and Oncology. 103:S48-S49
ISSN:	0167-8140
DOI:	10.1016/s0167-8140(12)72087-x
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e3d5dfde23b2edb597c0b4985e6d7c02 https://doi.org/10.1016/s0167-8140(12)72087-x Zobrazit plný text záznamu Full Text from ScienceDirect